AI‐enabled engineering of hesperidin/ursodeoxycholic acid nanomedicine for synergistic treatment of drug‐induced liver injury
Kai Xiao, Meng Fan, Haoyu Zheng, Boyuan Gu, Shaowen Wang, Ziping Wu, Shiming Zhang, Xin Zhao, Wensheng Zhang, Quanxin Ning, Sigen A, Chao Yang, Huayi Sun, Ren Mo, Dan Shao · 2026
Read AI‐enabled engineering of hesperidin/ursodeoxycholic acid nanomedicine for synergistic treatment of drug‐induced liver injury by Kai Xiao, Meng Fan, Haoyu Zheng, Boyuan Gu, Shaowen Wang, Ziping Wu, Shiming Zhang, Xin Zhao, Wensheng Zhang, Quanxin Ning, Sigen A, Chao Yang, Huayi Sun, Ren Mo, Dan Shao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13539393.txt.
Description
Kai Xiao and co-authors use AI to design a two-drug nanomedicine for drug-damaged livers, in a paper dated 2026. Drug-induced liver injury resists single drugs because it advances on several fronts at once: inflammation, oxidative stress, and failing repair. Clinic antioxidants touch only one front.
The team's framework starts from the disease itself. Time-series gene data from injured livers exposed two complementary repair axes: quieting a cytokine signaling route and boosting glutathione production, the cell's own antioxidant. A deep learning model then screened approved drug ingredients for molecules matching those twin goals. Two emerged, a citrus flavonoid and a bile acid, which conveniently self-assemble into uniform nanoparticles. The approach pairs diagnosis of mechanism with drug selection, instead of screening blindly.
Catalog record
| CREATOR | Kai Xiao, Meng Fan, Haoyu Zheng, Boyuan Gu, Shaowen Wang, Ziping Wu, Shiming Zhang, Xin Zhao, Wensheng Zhang, Quanxin Ning, Sigen A, Chao Yang, Huayi Sun, Ren Mo, Dan Shao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |